Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of r2 relaxometry with mri in patients with β-thalassemia major

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 4, 2009, Pages 853-859

  Papakonstantinou, Olympia ^a   Alexopoulou, Efthymia ^a   Economopoulos, Nikos ^a   Benekos, Odysseas ^a   Kattamis, Antonis ^b   Kostaridou, Stavroula ^b   Ladis, Vasilis ^a   Efstathopoulos, Efstathios ^a   Gouliamos, Athanassios ^a   Kelekis, Nikolaos L ^a,c  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c General National Hospital   (Greece)

Author keywords

Iron overload; MRI; R2 relaxometry; Thalassemia

Indexed keywords

IRON;

ADULT; ARTICLE; BETA THALASSEMIA; BONE MARROW; CARR PURCELL MEIBOOM GILL SPIN ECHO SEQUENCE; CHILD; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HUMAN; LIVER; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS; PRIORITY JOURNAL; RADIOGRAPHY; SCHOOL CHILD; SIDEROSIS; SMOOTH MUSCLE RELAXATION; SPLEEN; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE MARROW; CHILD; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIUM; PANCREAS; SPLEEN;

EID: 65249141150     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21707     Document Type: Article

References (41)

1. Rund D, Rachmilewitz E. Thalassemia. N Engl J Med 2005;353: 1135-1146.
2. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y Acad Sci 2005;1054:445- 450.
3. Alexopoulou E, Stripeli F, Baras P, et al. R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 2006;23:163-170.
4. Anderson LJ, Westwood MA, Holden S, et al. Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 2004;127:348-355.
5. Christoforidis A, Haritandi A, Tsatra I, Tsitourides I, Karyda S, Athanassiou-Metaxa M. Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens. Eur J Haematol 2007;78:52-57.
6. Kattamis A, Ladis V, Berdousi H, et al. Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12- month trial. Blood Cells Mol Dis 2006;36:21-25.
7. Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*. Hemoglobin 2006;30: 219 -227.
8. Pennell D. MRI and iron-overload cardiomyopathy in thalassaemia. Circulation 2006;113:43-44.
9. Song R, Cohen AR, Song HK. Improved transverse relaxation rate measurement techniques for the assessment of hepatic and myocardial iron content. J Magn Reson Imaging 2007;26:208-214.
10. St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
11. Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ. Multi center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica 2006;91:1388-1391.
12. Voskaridou E, Douskou M, Terpos E, et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 2004;126: 736-742.
13. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2*cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging2003; 18:33-39.
14. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2*mapping accurately estimates hepatic iron concentration in transfusion- dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
15. St Pierre zfnTG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 2005;1054:379-385.
16. He T, Gatehouse PD, Anderson LJ, et al. Development of a novel optimized breathhold technique for myocardial T2 measurement in thalassemia. J Magn Reson Imaging 2006;24:580-585.
17. Penell DJ. T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 2005;1054:373-378
18. He T, Gatehouse PD, Kirk PMohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. J Magn Reson Imaging 2008;60:350-356.
19. Lam WWM, Au WY, Chu WCW, Tam S, Ha SY, Penell DJ. One-stop measurement of iron deposition in the anterior pituitary, liver and heart in thalassemia patients. J Magn Reson Imaging 2008;28:29- 33.
20. Siegelman ES, Mitchell DG, Rubin R, et al. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 1991;179:361-366.
21. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
22. Argyropoulou MI, Kiortsis DN, Astrakas L, Metafratzi Z, Chalissos N, Efremidis SC. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol 2007;17:3025-3030.
23. Argyropoulou MI, Kiortsis DN, Efremidis SC. MRI of the liver and the pituitary gland in patients with beta-thalassemia major: does hepatic siderosis predict pituitary iron deposition? Eur Radiol 2003;13:12-16.
24. Drakonaki E, Papakonstantinou O, Maris T, Vasiliadou A, Pa- padakis A, Gourtsoyiannis N. Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores. Eur Radiol 2005;15:2462-2468.
25. Drakonaki E, Maris TG, Papadakis A, Karantanas A. Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores. Eur Radiol 2007;17:2079- 2087.
26. Midiri M, Lo Casto A, Sparacia G, et al. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major. Am J Roentgenol 1999;173:187-192.
27. Ooi GC, KhongPL, Chan GC, et al. Magnetic resonance screening of iron status in transfusion-dependent beta- thalassaemia patients. Br J Haematol 2004;124:385-390.
28. Papakonstantinou O, Drakonaki EE, Maris T, Vasiliadou A, Papadakis A, Gourtsoyiannis N. MR imaging ofspleen in beta-thalas- semia major. Abdom Imaging 2006 (in press).
29. Papakonstantinou O, Ladis V, Kostaridou S, et al. The pancreas in beta-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbances. Eur Radiol 2007;17:1535- 1543.
30. Au WY, Lam WW, Chu W, et al. A T2*magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica 2008;93:116-119.
31. Andersen C, Jensen FT. Precision, accuracy and image plane uniformity in NMR relaxation time imaging on a 1.5 T whole body MR imaging system. Magn Reson Imaging 1994;12:775-784.
32. In Den Kleef JJE, Cuppen JJM. RLSQ: t1, T2 and ρ calculations, combining ratios and least squares. Magn Reson Med 1987;5:513- 524.
33. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 1997;7:246-248.
34. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with β-thalassemia major. Pediatr Radiol 2007;37: 1191-1200.
35. Gossuin Y, Muller RN, Gillis P, Bartel L. Relaxivities ofhuman liver and spleen ferritin. Magn Reson Imaging 2005;23:1001-1004.
36. Hacket S, Chua-Anusorn W, Pootrakul P, St Pierre TG. The magnetic susceptibilities of iron deposits in thalassaemic spleen tissue. Biochi Biophys Acta 2007;1722:330-337
37. Hershko C, Link G, Cabantchik I. Pathophysiology ofiron overload. Ann N Y Acad Sci 1998;850:191-201.
38. Macdonald RA, Mallory GK. Hemochromatosis and hemosiderosis. Studyof211 autopsied cases. Arch Intern Med 1960;105:686-700.
39. Gillis P, Koening SH. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite. Magn Reson Med 1987;5:323-345.
40. Gossuin Y, Muller RN, Gillis P. Relaxation induced by ferritin: a better understanding or an improved MRI iron quantification. NMR Biomed 2004;17:427-432.
41. Grover R, Wethers DL. Spleen dysfunction in hemoglobinopathies determined by pitted red cells. Am J Pediatr Hematol Oncol 1988; 10:340-343.